FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3145606418> ?p ?o ?g. }

• W3145606418 abstract "Previous research indicated that the tumor cells and microenvironment interactions are critical for the immunotherapeutic response. However, predicting the clinical response to immunotherapy remains a dilemma for clinicians. Hence, this study aimed to investigate the associations between EVA1B expression and prognosis and tumor-infiltrating immune cells in glioma.Firstly, we detected the EVA1B expression in glioma tissues through biological databases. The chi-squared test, Kaplan-Meier, and univariate and multivariate Cox regression analyses were used to analyze the clinical significance of EVA1B expression. The correlation between EVA1B expression and levels of tumor-infiltrating immune cells in glioma tissues was investigated. Receiver operating characteristic (ROC) analysis was performed to compare the predictive power between EVA1B and other commonly immune-related markers.In the CGGA cohort of 325 glioma patients, we found that EVA1B was upregulated in glioma, and increased with tumor grade. High EVA1B expression was prominently associated with unfavorable clinicopathological features, and poorer survival of patients, which were further confirmed by TCGA (n=609) and GEO (n=74) cohorts. Furthermore, multivariate analysis indicated that EVA1B is an independent prognostic biomarker for glioma. Importantly, EVA1B overexpression was associated with a higher infiltration level of CD4+ T cells, CD8+ T cells, B cells, macrophages, and neutrophils in glioma. ROC curves showed that, compared with PD-L1, CTLA-4, and Siglec15, EVA1B presented a higher area under the curve (AUC) value (AUC=0.824) for predicting high immune infiltration levels in glioma.We found that EVA1B was upregulated and could act as a poor prognostic biomarker in glioma. Importantly, EVA1B overexpression was associated with the immune infiltration levels of immune cells including B cells, CD4+ T cells, CD8+ T cells, macrophages, and neutrophils, and strongly with the overall immune infiltration levels of glioma. These findings suggested that EVA1B might be a potential biomarker for evaluating prognosis and immune infiltration in glioma." @default.
• W3145606418 created "2021-04-13" @default.
• W3145606418 creator A5006250732 @default.
• W3145606418 creator A5006435389 @default.
• W3145606418 creator A5063631303 @default.
• W3145606418 date "2021-04-06" @default.
• W3145606418 modified "2023-10-15" @default.
• W3145606418 title "EVA1B to Evaluate the Tumor Immune Microenvironment and Clinical Prognosis in Glioma" @default.
• W3145606418 cites W1966107523 @default.
• W3145606418 cites W1975054545 @default.
• W3145606418 cites W1983955583 @default.
• W3145606418 cites W1985213868 @default.
• W3145606418 cites W2043946707 @default.
• W3145606418 cites W2096064375 @default.
• W3145606418 cites W2100930818 @default.
• W3145606418 cites W2128635779 @default.
• W3145606418 cites W2155654588 @default.
• W3145606418 cites W2256209050 @default.
• W3145606418 cites W2304850680 @default.
• W3145606418 cites W2537892258 @default.
• W3145606418 cites W2598968190 @default.
• W3145606418 cites W2754070259 @default.
• W3145606418 cites W2755134217 @default.
• W3145606418 cites W2765224588 @default.
• W3145606418 cites W2767377392 @default.
• W3145606418 cites W2794577178 @default.
• W3145606418 cites W2891760302 @default.
• W3145606418 cites W2896381750 @default.
• W3145606418 cites W2911294181 @default.
• W3145606418 cites W2911335821 @default.
• W3145606418 cites W2912770883 @default.
• W3145606418 cites W2942603595 @default.
• W3145606418 cites W2952293896 @default.
• W3145606418 cites W2952820297 @default.
• W3145606418 cites W2962368312 @default.
• W3145606418 cites W2977317690 @default.
• W3145606418 cites W2978810676 @default.
• W3145606418 cites W2982373666 @default.
• W3145606418 cites W3002319954 @default.
• W3145606418 cites W3045099554 @default.
• W3145606418 cites W3046771604 @default.
• W3145606418 cites W3088329234 @default.
• W3145606418 cites W3092885155 @default.
• W3145606418 cites W3125329324 @default.
• W3145606418 cites W4249273120 @default.
• W3145606418 doi "https://doi.org/10.3389/fimmu.2021.648416" @default.
• W3145606418 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8056259" @default.
• W3145606418 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33889156" @default.
• W3145606418 hasPublicationYear "2021" @default.
• W3145606418 type Work @default.
• W3145606418 sameAs 3145606418 @default.
• W3145606418 citedByCount "15" @default.
• W3145606418 countsByYear W31456064182021 @default.
• W3145606418 countsByYear W31456064182022 @default.
• W3145606418 countsByYear W31456064182023 @default.
• W3145606418 crossrefType "journal-article" @default.
• W3145606418 hasAuthorship W3145606418A5006250732 @default.
• W3145606418 hasAuthorship W3145606418A5006435389 @default.
• W3145606418 hasAuthorship W3145606418A5063631303 @default.
• W3145606418 hasBestOaLocation W31456064181 @default.
• W3145606418 hasConcept C10515644 @default.
• W3145606418 hasConcept C126322002 @default.
• W3145606418 hasConcept C143998085 @default.
• W3145606418 hasConcept C167672396 @default.
• W3145606418 hasConcept C203014093 @default.
• W3145606418 hasConcept C2776107976 @default.
• W3145606418 hasConcept C2777701055 @default.
• W3145606418 hasConcept C2778227246 @default.
• W3145606418 hasConcept C2781197716 @default.
• W3145606418 hasConcept C502942594 @default.
• W3145606418 hasConcept C50382708 @default.
• W3145606418 hasConcept C55493867 @default.
• W3145606418 hasConcept C58471807 @default.
• W3145606418 hasConcept C71924100 @default.
• W3145606418 hasConcept C86803240 @default.
• W3145606418 hasConcept C8891405 @default.
• W3145606418 hasConceptScore W3145606418C10515644 @default.
• W3145606418 hasConceptScore W3145606418C126322002 @default.
• W3145606418 hasConceptScore W3145606418C143998085 @default.
• W3145606418 hasConceptScore W3145606418C167672396 @default.
• W3145606418 hasConceptScore W3145606418C203014093 @default.
• W3145606418 hasConceptScore W3145606418C2776107976 @default.
• W3145606418 hasConceptScore W3145606418C2777701055 @default.
• W3145606418 hasConceptScore W3145606418C2778227246 @default.
• W3145606418 hasConceptScore W3145606418C2781197716 @default.
• W3145606418 hasConceptScore W3145606418C502942594 @default.
• W3145606418 hasConceptScore W3145606418C50382708 @default.
• W3145606418 hasConceptScore W3145606418C55493867 @default.
• W3145606418 hasConceptScore W3145606418C58471807 @default.
• W3145606418 hasConceptScore W3145606418C71924100 @default.
• W3145606418 hasConceptScore W3145606418C86803240 @default.
• W3145606418 hasConceptScore W3145606418C8891405 @default.
• W3145606418 hasLocation W31456064181 @default.
• W3145606418 hasLocation W31456064182 @default.
• W3145606418 hasOpenAccess W3145606418 @default.
• W3145606418 hasPrimaryLocation W31456064181 @default.
• W3145606418 hasRelatedWork W2904909612 @default.
• W3145606418 hasRelatedWork W3089283437 @default.
• W3145606418 hasRelatedWork W3177607563 @default.
• W3145606418 hasRelatedWork W3187744858 @default.

• next